lidocaine has been researched along with Chronic Hepatitis in 9 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lidocaine (LID) is an aminoethylamide used in hepatology to perform the monoethylglycinexylidide (MEGX) test for the evaluation of liver function in patients with cirrhosis (CIR) or chronic hepatitis (CH)." | 7.70 | The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis. ( Botta, F; Fasoli, A; Giannini, E; Risso, D; Romagnoli, P; Testa, R, 2000) |
| "To evaluate the role played by the immune system in the outcome of chronic C virus infection, we studied the peripheral blood lymphocyte subsets in patients with chronic hepatitis C and the correlation with the hepatic function assessed by the lidocaine test." | 5.08 | [The peripheral blood lymphocyte subpopulations in chronic anti-HCV-positive liver disease: their significance and correlation with liver function]. ( Biceglia, O; De Biasio, MC; De Crescenzo, OD; Forte, GB; Minerva, A; Paceli, M; Rocco, P, 1996) |
| "Lidocaine (LID) is an aminoethylamide used in hepatology to perform the monoethylglycinexylidide (MEGX) test for the evaluation of liver function in patients with cirrhosis (CIR) or chronic hepatitis (CH)." | 3.70 | The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis. ( Botta, F; Fasoli, A; Giannini, E; Risso, D; Romagnoli, P; Testa, R, 2000) |
| "Acute lymphoblastic leukemia (ALL) is the most common malignant neoplasm in children." | 1.33 | Assessment of liver function in children with acute lymphoblastic leukemia in remission. ( Kałdońska, M; Millo, B; Mokrzycka, M; Pawlik, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mokrzycka, M | 1 |
| Pawlik, A | 1 |
| Kałdońska, M | 1 |
| Millo, B | 1 |
| Reichel, C | 1 |
| Wienkoop, G | 1 |
| Nacke, A | 1 |
| Spengler, U | 1 |
| Forte, G | 1 |
| Rocco, P | 2 |
| Costanzo, A | 1 |
| Grimaldi, E | 1 |
| Rossi, R | 1 |
| Bottiglieri, ME | 1 |
| Biceglia, O | 2 |
| Zampella, G | 1 |
| Campo, N | 2 |
| Alvarez, S | 2 |
| Borzone, S | 1 |
| Caglieris, S | 2 |
| Zentilin, P | 1 |
| Testa, R | 3 |
| Paceli, M | 1 |
| Minerva, A | 1 |
| De Biasio, MC | 1 |
| De Crescenzo, OD | 1 |
| Forte, GB | 1 |
| Risso, D | 2 |
| Arzani, L | 1 |
| Giannini, E | 2 |
| Lantieri, PB | 1 |
| Celle, G | 1 |
| Botta, F | 1 |
| Fasoli, A | 1 |
| Romagnoli, P | 1 |
| Meyer, B | 1 |
| Luo, HS | 1 |
| Bargetzi, M | 1 |
| Renner, EL | 1 |
| Stalder, GA | 1 |
| Villeneuve, JP | 1 |
| Thibeault, MJ | 1 |
| Ampelas, M | 1 |
| Fortunet-Fouin, H | 1 |
| LaMarre, L | 1 |
| Côté, J | 1 |
| Pomier-Layrargues, G | 1 |
| Huet, PM | 1 |
1 review available for lidocaine and Chronic Hepatitis
| Article | Year |
|---|---|
[Monoethylglycinexylidide (MEGX)-test. A test for the assessment of prognosis before and after liver transplantation].
Topics: Fluorescence Polarization Immunoassay; Hepatitis, Chronic; Humans; Lidocaine; Liver; Liver Cirrhosis | 1995 |
1 trial available for lidocaine and Chronic Hepatitis
| Article | Year |
|---|---|
[The peripheral blood lymphocyte subpopulations in chronic anti-HCV-positive liver disease: their significance and correlation with liver function].
Topics: Adult; Biopsy; Female; Hepatitis C; Hepatitis, Chronic; Humans; Lidocaine; Liver; Liver Cirrhosis; L | 1996 |
7 other studies available for lidocaine and Chronic Hepatitis
| Article | Year |
|---|---|
Assessment of liver function in children with acute lymphoblastic leukemia in remission.
Topics: Adolescent; Adult; Area Under Curve; Child; Diagnosis, Differential; Female; Half-Life; Hepatitis, C | 2006 |
Monoethylglycinexylidide production as a measure in predicting hepatic histology.
Topics: Adult; Biomarkers; Female; Hepatitis, Chronic; Humans; Injections, Intravenous; Lidocaine; Liver Cir | 1994 |
Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
Topics: Adult; Esophagitis, Peptic; Hepatitis C; Hepatitis, Chronic; Humans; Lidocaine; Male; Mixed Function | 1994 |
Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease.
Topics: Adolescent; Adult; Age Factors; Aged; Anesthetics, Local; Case-Control Studies; Diagnosis, Different | 1997 |
The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis.
Topics: Adult; Aged; Female; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Lidocaine; Liver Cirrhosis; | 2000 |
Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: support for the intact-hepatocyte theory.
Topics: Adrenergic beta-Antagonists; Ethanolamines; Hepatitis, Chronic; Humans; Lidocaine; Liver; Liver Cirr | 1991 |
Drug disposition in patients with HBsAg-positive chronic liver disease.
Topics: Adult; Aminopyrine; Antipyrine; Female; Hepatitis; Hepatitis B Surface Antigens; Hepatitis, Chronic; | 1987 |